Antibodies

Items 41-50 of 66

per page
Set Descending Direction
  1. anti-PARP-1 [ARTD1] (mouse), pAb
    AG-25T-0001
    AG-25T-0001-R100100 µl
    CHF 340.00
  2. anti-PARP-10 [ARTD10] (human), mAb (5H11)
    AG-20T-0004
    AG-20T-0004-L0011 ml
    CHF 380.00
    Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). Method: T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci
  3. anti-PARP-2 [ARTD2] (mouse), pAb
    AG-25T-0003
    AG-25T-0003-R100100 µl
    CHF 350.00
  4. anti-Phosphothreonine, Rabbit Monoclonal (RM102)
    REV-31-1009-00
    REV-31-1009-00-C100100 µg
    CHF 518.00
    Immunocytochemistry of serum-starved A431 cells nontreated or treated with Calyculin A/ Okadaic Acid, using RevMAb Clone RM102 at 1/500 dilution (followed by PE conjugated secondary antibody, red) and DAPI (blue).
  5. anti-Phosphotyrosine, Rabbit Monoclonal (RM111)
    REV-32-1011-00
    REV-32-1011-00-C100100 µg
    CHF 518.00
    Immunocytochemistry of serum-starved A431 cells nontreated or treated with EGF, using RevMAb Clone RM111 at 1/500 dilution (foll-owed by a PE conjugated secondary antibody, red) and DAPI (blue).
  6. anti-PIDD, pAb (AL233)
    AG-25B-0015
    AG-25B-0015-C05050 µg
    CHF 270.00
    anti-PIDD, pAb (AL233)
  7. anti-Podoplanin (mouse), mAb (RTD4E10)
    AG-20T-0101
    AG-20T-0101-C100100 µg
    CHF 460.00
  8. anti-Polyglutamylation Modification, mAb (GT335)
    AG-20B-0020
    AG-20B-0020-C100100 µg
    CHF 495.00
    Western blot analysis of protein glutamylation with MAb to polyglutamylation modification (GT335) (Prod. No. AG-20B-0020).
Method: HeLa cells grown in standard culture conditions are lysed in SDS sample buffer and run on 10% SDS-PAGE. The pro
  9. anti-Polyglutamylation Modification, mAb (GT335) (Biotin)
    AG-20B-0020B
    AG-20B-0020B-C100100 µg
    CHF 530.00

Items 41-50 of 66

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.